ANNUAL ERADICATION RATE OF BISMUTH-CONTAINING QUADRUPLE THERAPY AS SECOND-LINE TREATMENT FOR HELICOBACTER PYLORI INFECTION: A 15-YEAR PROSPECTIVE STUDY AT A TERTIARY HOSPITAL IN KOREA

被引：0
|
作者：
Kim, Nayoung
Yoon, Kichul
Lee, Dong Ho
机构：
来源：
GASTROENTEROLOGY | 2020年 / 158卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Su1379
引用
收藏
页码：S571 / S571
页数：1
相关论文
共 50 条
  • [21] Quadruple therapy should be second-line treatment for Helicobacter pylori infection
    Axon, A
    HELICOBACTER PYLORI: BASIC MECHANISMS TO CLINICAL CURE 2000, 2000, : 631 - 635
  • [22] Comparative study of allicin-containing quadruple therapy vs. bismuth-containing quadruple therapy for the treatment of Helicobacter pylori infection: a prospective randomized study
    Li, Huan
    Xia, Xiu-Juan
    Zhang, Lin-Fang
    Chi, Jing-Shu
    Liu, Peng
    Wu, Hao
    Xie, Xiao-Ran
    Tian, De-Lin
    Kun, Kai-Xiao
    Gong, Ren-Jie
    Liu, Xiao-Ming
    Xu, Can-Xia
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 33 (02) : 194 - 200
  • [23] Modified quadruple therapy or bismuth-containing quadruple therapy in the first-line treatment of Helicobacter pylori in Turkey
    Yozgat, Ahmet
    Kasapoglu, Benan
    Demirci, Selim
    Sokmen, Fevzi Coskun
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2021, 113 (07) : 490 - 493
  • [24] SECOND-LINE HELICOBACTER PYLORI ERADICATION THERAPY AFTER FAILURE OF NON-BISMUTH QUADRUPLE "CONCOMITANT" TREATMENT
    Kim, S.
    Choe, J.
    Jung, S.
    Park, J.
    Chun, H.
    Lee, S.
    HELICOBACTER, 2015, 20 : 92 - 92
  • [25] Eradication Efficacy of Modified Dual Therapy Compared with Bismuth-Containing Quadruple Therapy as a First-Line Treatment of Helicobacter pylori
    Yang, Jing
    Zhang, Yi
    Fan, Ling
    Zhu, Yang-Jie
    Wang, Ting-Yi
    Wang, Xing-Wei
    Chen, Dong-Feng
    Lan, Chun-Hui
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 (03): : 437 - 445
  • [26] Efficacy and safety of twice a day, bismuth-containing quadruple therapy using high-dose tetracycline and metronidazole for second-line Helicobacter pylori eradication
    Kim, Ji Yeon
    Lee, Sun-Young
    Kim, Jeong Hwan
    Sung, In-Kyung
    Park, Hyung Seok
    HELICOBACTER, 2020, 25 (02)
  • [27] THE TREND OF ERADICATION RATES OF FIRST LINE THERAPY AND SECOND LINE QUADRUPLE THERAPY CONTAINING METRONIDAZOLE FOR HELICOBACTER PYLORI INFECTION IN KOREA
    Song, J.
    Chung, I.
    HELICOBACTER, 2011, 16 : 137 - 137
  • [28] Helicobacter pylori second-line rescue therapy with levofloxacin- and bismuth-containing quadruple therapy, after failure of standard triple or non-bismuth quadruple treatments
    Gisbert, J. P.
    Romano, M.
    Gravina, A. G.
    Solis-Munoz, P.
    Bermejo, F.
    Molina-Infante, J.
    Castro-Fernandez, M.
    Ortuno, J.
    Lucendo, A. J.
    Herranz, M.
    Modolell, I.
    del Castillo, F.
    Gomez, J.
    Barrio, J.
    Velayos, B.
    Gomez, B.
    Dominguez, J. L.
    Miranda, A.
    Martorano, M.
    Algaba, A.
    Pabon, M.
    Angueira, T.
    Fernandez-Salazar, L.
    Federico, A.
    Marin, A. C.
    McNicholl, A. G.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2015, 41 (08) : 768 - 775
  • [29] THE EFFECT OF MOXIFLOXACIN CONTAINING TRIPLE THERAPY AS SECOND-LINE TREATMENT FOR HELICOBACTER PYLORI ERADICATION INFECTION
    Hwang, J.
    Lee, D.
    Yoon, K.
    Lee, H.
    Jeong, Y.
    Kwon, Y.
    Lee, A.
    Yoon, H.
    Shin, C.
    Park, Y.
    Kim, N.
    Seol, S.
    Jung, H.
    HELICOBACTER, 2014, 19 : 139 - 139
  • [30] Eradication rate of Helicobacter pylori using bismuth-containing quadruple therapy in central area of Seoul, South Korea, for the past 5 years
    Choi, Jong Hyun
    Kang, Young Mo
    Park, Jee Hyun
    Park, Tae Young
    Ryu, Soo Hyung
    Kim, You Sun
    Moon, Jeong Seop
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 : 352 - 352
12345